Recombinant human antibody found safe in Transthyretin amyloid cardiomyopathy and chronic HF patients: NEJM Aditi27 July 2023 10:30 AM ISTA recent trial has investigated the safety and side-effect profile and the pharmacokinetic and pharmacodynamic profile of the human anti-ATTR antibody...
Dersimelagon significantly increased duration of symptom-free sunlight exposure in erythropoietic protoporphyria: NEJM Aditi27 July 2023 10:00 AM ISTA study entitled "Dersimelagon in Erythropoietic Protoporphyrias", published in the New England Journal of Medicine, has concluded that at 16 weeks,...
Blinatumomab promising for treatment of aggressive infant leukemia with 81.6% disease-free survival rate: NEJM Dr. Mahalakshmi Sivashankaran9 May 2023 8:00 PM ISTNetherlands: In a study conducted by researchers, Blinatumomab, a bispecific T-cell engager molecule, to be safe and efficacious for infants with...
Cerebral oximetry monitoring in preterm infants does not reduce death or brain injury risk: NEJM Dr. Mahalakshmi Sivashankaran9 May 2023 10:30 AM ISTDenmark: A new study published in the New England Journal of Medicine has found that the use of cerebral oximetry monitoring in the care of extremely...
Osmotic demyelination syndrome a rare complication of hyponatremia Dr. Mahalakshmi Sivashankaran6 May 2023 8:15 AM ISTCanada: A new study published in NEJM: Evidence has found that rapid correction of serum sodium is a common occurrence in patients with hyponatremia,...
Antidepressant augmentation with aripiprazole improves well-being in treatment-resistant depression: NEJM Aditi3 May 2023 10:00 AM ISTAn original article published in the New England Journal of Medicine has highlighted that Antidepressant augmentation with aripiprazole improved...
Sex of Blood Donor not linked to mortality risk among recipients after red cell transfusion: NEJM Aditi25 April 2023 8:00 PM ISTAn Original article entitled, "Effect of Donor Sex on Recipient Mortality in Transfusion" by lead researcher Dr Michael Chasse, M.D., PhD has...
High dose steroids Linked to Increased Covid-19 Mortality in Non-Oxygenated Hospitalized Patients: NEJM Dr. Mahalakshmi Sivashankaran25 April 2023 11:30 AM ISTItaly: A new study published in NEJM Evidence has found that the use of glucocorticoids in hospitalized patients with COVID-19 who are not receiving...
Prophylactic Tranexamic acid usage fails to substantially reduce post C-section bleeding Dr.Niharika Harsha B15 April 2023 9:15 AM ISTAccording to a new study,Tranexamic acid appears no more effective than placebo in reducing the need for blood transfusion or preventing maternal...
73 percent of patients in two clinical trials exhibit success in experimental cancer therapy Isra Zaman12 Dec 2022 9:45 AM ISTNearly all patients with myeloma who receive standard therapies continually relapse. Patients who relapse or become resistant to all approved...
Empagliflozin reduces risk of disease progression and death in high-risk CKD patients: NEJM Medha Baranwal7 Nov 2022 10:30 AM ISTUK: Empagliflozin therapy in patients with chronic kidney disease (CKD) lowers the risk of disease progression or death from cardiovascular causes in...
Does cerebral embolic protection prevent stroke in patients undergoing TAVR? PROTECTED TAVR provides answer Medha Baranwal10 Oct 2022 8:00 PM ISTUSA: The use of cerebral embolic protection (CEP) among patients with aortic stenosis undergoing transfemoral TAVR did not reduce the risk of...
